FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2019756490> ?p ?o ?g. }

• W2019756490 endingPage "854" @default.
• W2019756490 startingPage "848" @default.
• W2019756490 abstract "Historically, VHL was the only frequently mutated gene in clear cell renal cell carcinoma (ccRCC), with conflicting clinical relevance. Recent sequencing efforts have identified several novel frequent mutations of histone modifying and chromatin remodeling genes in ccRCC including PBRM1, SETD2, BAP1, and KDM5C. PBRM1, SETD2, and BAP1 are located in close proximity to VHL within a commonly lost (approximately 90%) 3p locus. To date, the clinical and pathologic significance of mutations in these novel candidate tumor suppressors is unknown. To determine the frequency of and render the first clinical and pathologic outcome associated with mutations of these novel candidate tumor suppressors in ccRCC. Targeted sequencing was performed in 185 ccRCCs and matched normal tissues from a single institution. Pathologic features, baseline patient characteristics, and follow-up data were recorded. The linkage between mutations and clinical and pathologic outcomes was interrogated with the Fisher exact test (for stage and Fuhrman nuclear grade) and the permutation log-rank test (for cancer-specific survival [CSS]). PBRM1, BAP1, SETD2, and KDM5C are mutated at 29%, 6%, 8%, and 8%, respectively. Tumors with mutations in PBRM1 or any of BAP1, SETD2, or KDM5C (19%) are more likely to present with stage III disease or higher (p = 0.01 and p = 0.001, respectively). Small tumors (<4 cm) with PBRM1 mutations are more likely to exhibit stage III pathologic features (odds ratio: 6.4; p = 0.001). BAP1 mutations tend to occur in Fuhrman grade III–IV tumors (p = 0.052) and are associated with worse CSS (p = 0.01). Clinical outcome data are limited by the number of events. Most mutations of chromatin modulators discovered in ccRCC are loss of function, associated with advanced stage, grade, and possibly worse CSS. Further studies validating the clinical impact of these novel mutations and future development of therapeutics remedying these tumor suppressors are warranted." @default.
• W2019756490 created "2016-06-24" @default.
• W2019756490 creator A5003119579 @default.
• W2019756490 creator A5010536553 @default.
• W2019756490 creator A5019708503 @default.
• W2019756490 creator A5021734597 @default.
• W2019756490 creator A5023007737 @default.
• W2019756490 creator A5025018584 @default.
• W2019756490 creator A5028587910 @default.
• W2019756490 creator A5030709443 @default.
• W2019756490 creator A5049612841 @default.
• W2019756490 creator A5051277222 @default.
• W2019756490 creator A5059063118 @default.
• W2019756490 creator A5060705907 @default.
• W2019756490 creator A5061030806 @default.
• W2019756490 creator A5081581200 @default.
• W2019756490 creator A5086226688 @default.
• W2019756490 creator A5091859782 @default.
• W2019756490 date "2013-05-01" @default.
• W2019756490 modified "2023-10-17" @default.
• W2019756490 title "Clinical and Pathologic Impact of Select Chromatin-modulating Tumor Suppressors in Clear Cell Renal Cell Carcinoma" @default.
• W2019756490 cites W1511815964 @default.
• W2019756490 cites W1520588455 @default.
• W2019756490 cites W1571627051 @default.
• W2019756490 cites W1977845140 @default.
• W2019756490 cites W1999491723 @default.
• W2019756490 cites W2007265317 @default.
• W2019756490 cites W2008285831 @default.
• W2019756490 cites W2008809596 @default.
• W2019756490 cites W2015416439 @default.
• W2019756490 cites W2024064023 @default.
• W2019756490 cites W2057802075 @default.
• W2019756490 cites W2060605982 @default.
• W2019756490 cites W2072257321 @default.
• W2019756490 cites W2079212177 @default.
• W2019756490 cites W2085531754 @default.
• W2019756490 cites W2092892924 @default.
• W2019756490 cites W2095698093 @default.
• W2019756490 cites W2103313018 @default.
• W2019756490 cites W2106417221 @default.
• W2019756490 cites W2106797333 @default.
• W2019756490 cites W2111326065 @default.
• W2019756490 cites W2115494288 @default.
• W2019756490 cites W2126675803 @default.
• W2019756490 cites W2150575159 @default.
• W2019756490 cites W2161609794 @default.
• W2019756490 cites W2331498988 @default.
• W2019756490 cites W4238906713 @default.
• W2019756490 doi "https://doi.org/10.1016/j.eururo.2012.09.005" @default.
• W2019756490 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3615105" @default.
• W2019756490 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23036577" @default.
• W2019756490 hasPublicationYear "2013" @default.
• W2019756490 type Work @default.
• W2019756490 sameAs 2019756490 @default.
• W2019756490 citedByCount "195" @default.
• W2019756490 countsByYear W20197564902013 @default.
• W2019756490 countsByYear W20197564902014 @default.
• W2019756490 countsByYear W20197564902015 @default.
• W2019756490 countsByYear W20197564902016 @default.
• W2019756490 countsByYear W20197564902017 @default.
• W2019756490 countsByYear W20197564902018 @default.
• W2019756490 countsByYear W20197564902019 @default.
• W2019756490 countsByYear W20197564902020 @default.
• W2019756490 countsByYear W20197564902021 @default.
• W2019756490 countsByYear W20197564902022 @default.
• W2019756490 countsByYear W20197564902023 @default.
• W2019756490 crossrefType "journal-article" @default.
• W2019756490 hasAuthorship W2019756490A5003119579 @default.
• W2019756490 hasAuthorship W2019756490A5010536553 @default.
• W2019756490 hasAuthorship W2019756490A5019708503 @default.
• W2019756490 hasAuthorship W2019756490A5021734597 @default.
• W2019756490 hasAuthorship W2019756490A5023007737 @default.
• W2019756490 hasAuthorship W2019756490A5025018584 @default.
• W2019756490 hasAuthorship W2019756490A5028587910 @default.
• W2019756490 hasAuthorship W2019756490A5030709443 @default.
• W2019756490 hasAuthorship W2019756490A5049612841 @default.
• W2019756490 hasAuthorship W2019756490A5051277222 @default.
• W2019756490 hasAuthorship W2019756490A5059063118 @default.
• W2019756490 hasAuthorship W2019756490A5060705907 @default.
• W2019756490 hasAuthorship W2019756490A5061030806 @default.
• W2019756490 hasAuthorship W2019756490A5081581200 @default.
• W2019756490 hasAuthorship W2019756490A5086226688 @default.
• W2019756490 hasAuthorship W2019756490A5091859782 @default.
• W2019756490 hasBestOaLocation W20197564902 @default.
• W2019756490 hasConcept C121608353 @default.
• W2019756490 hasConcept C126322002 @default.
• W2019756490 hasConcept C143998085 @default.
• W2019756490 hasConcept C191093355 @default.
• W2019756490 hasConcept C2777472916 @default.
• W2019756490 hasConcept C2778560582 @default.
• W2019756490 hasConcept C2781278892 @default.
• W2019756490 hasConcept C37846818 @default.
• W2019756490 hasConcept C502942594 @default.
• W2019756490 hasConcept C63363279 @default.
• W2019756490 hasConcept C71924100 @default.
• W2019756490 hasConceptScore W2019756490C121608353 @default.
• W2019756490 hasConceptScore W2019756490C126322002 @default.
• W2019756490 hasConceptScore W2019756490C143998085 @default.

• next